Theravance Biopharma, Inc. Cash Flow Statement

Cash Flow Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -9.57M-156.28M-237.04M-182.22M-190.67M-285.41M-215.49M-236.46M16.81M65.64M1143.93M-55.19M-63.99M
Depreciation and Depletion 2.70M2.70M2.50M2.20M2.50M3.00M3.30M3.30M3.50M2.60M1.90M1.60M
Share-based Compensation 21.32M22.48M43.23M54.05M41.17M49.15M51.31M60.45M62.98M62.06M39.73M25.37M21.39M
Deferred Taxes 3.21M-7.57M
Cash from Discontinued Operations 12.34M27.92M-184.57M
Gains from Sales and Divestitures 1.19M1.42M1.41M1.31M1.91M2.68M3.77M1.65M1.64M
Gains from Investment Securities -0.20M-0.02M4.55M13.39M-9.49M8.56M9.81M49.85M9.75M9.06M117.97M2.50M2.66M
Asset Writedowns and Impairment 2.89M2.10M0.30M0.74M4.51M
Non-cash Items 1.40M18.10M8.00M5.10M8.50M1.20M1.07M0.78M0.86M
Cash from Operations -119.11M-120.96M-175.16M-168.86M-98.99M-201.05M-112.87M-238.20M-262.75M-235.78M-186.99M-27.00M-11.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.61M3.22M3.34M3.79M3.99M4.15M4.41M
Amortization of Deferred Charges 3.22M
Depreciation & Amortization (CF) 3.25M2.65M3.27M2.99M3.12M3.80M4.48M6.44M4.71M4.80M3.72M2.00M1.71M
Change in Working Capital
Change in Receivables 0.62M0.20M0.09M1.63M-1.28M1.61M-1.63M-0.62M
Change in Inventory 4.82M3.10M6.63M-1.03M3.18M7.30M1.63M
Change in Account Payables -1.53M2.11M3.92M8.72M-16.44M3.80M3.58M-4.27M3.66M-3.53M-1.61M0.01M0.75M
Change in Accured Expenses -1.70M4.17M11.68M-1.04M17.19M8.33M-12.36M10.63M5.98M-37.23M-14.09M-7.09M1.47M
Change in Taxes 12.76M-9.52M7.89M-8.19M3.70M0.26M
Other Working Capital Changes -124.49M7.47M-7.99M1.16M9.69M24.45M69.22M-31.25M-26.46M-11.46M3.80M7.55M-7.40M
Investing Activities
Capital Expenditures 2.59M2.73M3.11M2.65M2.13M2.41M7.24M3.18M6.62M3.41M0.57M2.49M0.33M
Sales of Property, Plant and Equipment 0.02M0.01M0.06M0.01M1.87M1.51M
Divestments 20.00M5.00M1095.13M
Change in Acquisitions & Divestments 0.10M0.10M65.56M186.70M91.47M234.86M347.19M339.02M399.32M286.20M158.00M71.38M139.81M
Cash from Investing Activities -2.43M-2.63M-106.25M111.04M-148.24M-56.33M176.71M-83.05M10.72M124.49M1154.01M-32.70M12.28M
Financing Activities
Other financing activities 277.54M0.76M3.87M8.56M9.81M3.17M-16.80M9.06M-20.19M2.50M2.66M
Cash from Financing Activities 121.54M123.59M370.62M81.31M479.23M1.66M225.20M1.29M279.88M91.86M-758.81M-198.93M-2.50M
Additional items
Change in Cash 89.22M23.49M232.00M-255.73M289.04M-319.96M23.40M8.50M208.21M-258.63M-1.75M
Free Cash Flow -121.70M-123.69M-178.26M-171.50M-101.12M-203.46M-120.11M-241.37M-269.36M-239.18M-187.56M-29.48M-11.87M
Net Cash Flow 89.22M23.49M232.00M-255.73M289.04M-319.96M27.86M-19.42M208.21M-258.63M-1.75M